Individuals who developed a concerning adverse safety outcome were not censored and remained in any subsequent analysis
Metformin with GLP-RA Safe: Consistency with Prior Evidence These findings are consistent with earlier published evidence, a network meta-analysis of 34 RCTs across 10 GLP-1 RAs (n=12,993 patients) had previously confirmed that GLP-1 RAs added to metformin do not increase hypoglycaemia incidence and do not drive higher adverse event-related treatment discontinuation, lending further support to the favourable safety profile now confirmed through real-world pharmacovigilance data
Results Trends in GLP-1 RA sales Total GLP-1 RA sales increased almost 10-fold from 57,941 units in May 2020 to 496,875 units in April 2025 (Figure 1)
How GLP-1s Work And What That Means for Your Skin GLP-1 medications were originally developed to help people with type 2 diabetes help manage blood sugar, but they quickly became widely used for weight loss because of how they work
Mol Nutr Food Res (2008) 52(1):725
The prevalence of HFpEF is rising, increasing from 33 to 39% between 2005 and 2010, with projections suggesting it will soon become the most common form of HF [5, 6]